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generally negative perception of RO. The Belgian Radiation 
Oncology Awareness Organisation (BRAVO) is a collaborative 
platform of medical practitioners and industrial partners, 
created to evaluate and where required increase knowledge 
concerning radiation oncology by the general population, 
healthcare workers and policy makers. As a first step it was 
decided to assess the awareness of the general population. 
Materials and Methods: Between March and June 2014, data 
for this survey was collected during face-to-face streets 
interviews in all Belgian provinces. Questionnaires included 
fourteen questions articulated around four major themes: 
general awareness, efficacy, security and comfort, and 
innovation. Where required, open questions were used to 
avoid inducing answers. For most questions more then one 
answer was registered, and in that case the order of answers 
was noted. 
Results: Participants (n=746) were well balanced for gender 
and geographical distribution was homogeneous. Age 
distribution showed that a majority of participants was 
younger than 40 years (57%). We report here on a subset of 
questions. 
When looking at different therapeutic modalities for cancer, 
59 % of participants spontaneously cited RO as an option. 
However, when asked about the modality that offers the best 
cure chances, the RO score was well below surgery and 
chemotherapy with 13, 40 and 26% of positive answers 
respectively. Knowledge on treatment of cancer is mainly 
based on experiences in the personal environment (56%) and 
TV (37%), followed by written press (24%); the internet, 
school and hospitals being cited as other sources of 
information. 
On the safety issue, 33.8% of responders considered RO as an 
‘unsafe’ technique compared to 28.1% for whom it was 
‘safe’. RO was perceived as safe as chemotherapy, but less 
safe than surgery. Discussing potential side effects, 
participants seemed confused and cited problems induced by 
chemotherapy: 'hair loss' was more frequently mentioned 
(21%) than 'skin burns' (12%), with 36% having no idea about 
any radiotherapy toxicity. 
Lastly, asked about the treatment modality considered most 
innovative, radiotherapy came first (35%) before 
chemotherapy (31%) and surgery (16%). 
Conclusions: Knowledge of RO in Belgian general population 
is relatively poor and confusion with other treatment 
modalities exists. RT is not readily recognized as an effective 
treatment option and seems associated with insecurity. There 
is a clear need for future educational efforts targeted to the 
general population.  
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Purpose/Objective: Prospective evaluation of psychological 
variables including cut-off scores of psychological tests in 
aspect of outcome in  
head and neck cancer (HNC) patients treated by radiation 
alone, concurrent and sequential chemo-radiation. 
Materials and Methods: Eighty patients (women - 28%, men - 
72%, stage I/II - 17%, III - 15%, IV - 68%) were treated with by 
Accelerated Radiotherapy Alone (ARA - 60%) or Concurrent 
Chemo-Radiation (CCR - 40%) in some cases preceded by 
induction chemotherapy. The patients completed modified 
Hospital Anxiety and Depression Scale (HADS-M with 
additional aggression-irritability subscale), Distress 
Thermometer, Satisfaction with Life Scale, Visual–Analog 
Scales (VAS) of pain in HN area before (80 pts) and after (71 
pts) therapy. Clinical data, psychosocial and marital status of 
patients were included into the analysis as well.  
Results: Local control (LC) and overall survival (OS) rates at 3 
year follow-up were respectively 62% and 63%. At baseline, 
30% of patients were clinically depressed (15/42 or more 
points of general HADS score including depression and anxiety 
subscales). Overall HADS score was correlated with rates of 
3-year OS and LC, i.e. in patients with HADS <10p there were 
77% of LC and 73% of OS, but in HADS ≥10p there were 47% of 
LC and 54% of OS (p<0.021 and p<0.045, respectively). Fifty 
seven percent of patients reported baseline pain in HN area 
measured by VAS (42.5% - no pain, 27.5% - weak pain 1-3p, 
27.5% - moderate pain 4-6p, 2.5% - intense pain 7-10p). VAS 
score was correlated with rates of 3-year OS and LC, i.e. 
patients with moderate and intense pain of HN area (4-10p) 
had significantly lower LC and OS rates compare to patients 
with less pain (0-3p) – 29% and 32% versus 75% and 78%, 
respectively (p<0.00131, p<0.00033). Both HADS score and 
baseline VAS HN pain were not correlated with T and N stage, 
site of disease, age and sex. Baseline HADS score and HN pain 
intensity at baseline weakly correlated each other (R=0.24, 
p<0.05). Compared to the patients who had only CCR or ARA, 
induction chemotherapy group had 50% lower depression 
score after completing radiotherapy (p<0.05). Baseline C-
Reactive Protein level was related to increased depression 
and general higher HADS scores (R=0.31, p<0.05). Living 
alone without partner or family correlated with baseline HN 
pain (R=0.37, p<0.05) and stage of cancer (R=0.27, p<0.05). 
Conclusions: Baseline subclinical depressive symptomatology 
and elevated HN pain seem to play a significant role in the 
effectiveness of HNC radiation-related treatment, 
additionally to the other, well-known prognostic factors. 
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Ontologies can be used to increase data quality by describing 
the variables that are recorded in databases and the 
relationship between them. The definition of an ontology is 
“a formal description of the entities and the relationships 
between them for a given domain”. In radiation oncology, 
entities are classes like patients, diseases, CT-scans, 
radiotherapy treatments etc. and individuals like a specific 
MR scan or a specific treatment in a specific patient. 
Relationships can be simple such as specifying entities being 
sub classes, types, domains, ranges etc. of one another and 
data properties (e.g. dates) to more complex relationships 
such as a specific toxicity that occurred in a specific patient 
due to a specific radiotherapy treatment.  
